Search
for

    Sort by

    Research 121–150 of 321

    1. Dermatological Manifestations of COVID-19: A Comprehensive Review Physician s Journal of Medicine · 2025
    2. Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns Pharmacoepidemiology and Drug Safety · 2023
    3. Oral Presentations International Journal of Trichology · 2012
    4. Exploring Acne Treatments: From Pathophysiological Mechanisms to Emerging Therapies International Journal of Molecular Sciences · 2024 · 68 citations
    5. The Role of Sex and Gender in Dermatology - From Pathogenesis to Clinical Implications Journal of Cutaneous Medicine and Surgery · 2023 · 30 citations
    6. Dermoscopy of skin infestations and infections (entomodermoscopy) – Part I: dermatozoonoses and bacterial infections Anais Brasileiros de Dermatologia · 2021 · 13 citations
    7. Comparing the frequency of isotretinoin-induced hair loss at <0.5-mg/kg/d versus ≥0.5-mg/kg/d dosing in acne patients: A systematic review JAAD International · 2022 · 6 citations
    8. Off-label uses of retinoids in dermatology Our Dermatology Online · 2012 · 6 citations
    9. Effects of natural products on skin inflammation caused by abnormal hormones secreted by the adrenal gland Frontiers in Pharmacology · 2023 · 2 citations
    10. When bugs and drugs conspire: driving acneiform skin toxicity 2020 · 1 citations
    11. Microneedling radiofrequency in cosmetic dermatology and aesthetics Journal of the Egyptian Womenʼs Dermatologic Society · 2026
    12. JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology Medicina · 2026
    13. Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies Biomedicines · 2025
    14. Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists Dermatology and Therapy · 2025
    15. Unveiling the Nuances of Adult Female Acne: A Comprehensive Exploration of Epidemiology, Treatment Modalities, Dermocosmetics, and the Menopausal Influence International journal of women's health · 2024
    16. Active Compounds with Medicinal Potential Found in Maxillariinae Benth. (Orchidaceae Juss.) Representatives—A Review International Journal of Molecular Sciences · 2023
    17. Association of Acne Tarda with Endocrinological Disorders Dermato · 2022
    18. Subject Index Journal of the American Academy of Dermatology · 2009
    19. Activation of TRPV3 Regulates Inflammatory Actions of Human Epidermal Keratinocytes Journal of Investigative Dermatology · 2017 · 77 citations
    20. An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer Journal of Clinical Medicine · 2025
    21. Medical Dermatology Australasian Journal of Dermatology · 2024 · 2 citations
    22. Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations Frontiers in Oncology · 2026
    23. PA11 A rare case of a severe papulopustular dermatosis secondary to a germline <i>EGFR</i> mutation British Journal of Dermatology · 2026
    24. PRIDE Complex (Papulopustules and/or Paronychia, Regulatory Abnormalities of Hair Growth, Itching, Dryness Due to EGFR Inhibitors) JEADV Clinical Practice · 2025
    25. The PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) syndrome British Journal of Dermatology · 2006 · 90 citations
    26. Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients Journal of Cutaneous Pathology · 2015 · 9 citations
    27. Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara<sup>®</sup>) and EE/LNG (Microgynon<sup>®</sup>) Dermatology · 2001 · 88 citations
    28. Dermatologic adverse events associated with afatinib: an oral ErbB family blocker Expert Review of Anticancer Therapy · 2013 · 87 citations
    29. Advances in the Management of Cutaneous Toxicities of Targeted Therapies Seminars in Oncology · 2012 · 42 citations
    30. Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor PLoS ONE · 2012 · 32 citations